Iizuka, Y.; Sasaki, M.; Terada, K.; Sakai, T.; Nagaoka, Y.; Fukumura, S.; Kocsis, J.D.; Tsugawa, T.; Honmou, O.
Therapeutic Efficacy of Mesenchymal Stem Cells in Modulating Oxidative Stress in Puromycin-Induced Nephropathy. Pathophysiology 2025, 32, 19.
https://doi.org/10.3390/pathophysiology32020019
AMA Style
Iizuka Y, Sasaki M, Terada K, Sakai T, Nagaoka Y, Fukumura S, Kocsis JD, Tsugawa T, Honmou O.
Therapeutic Efficacy of Mesenchymal Stem Cells in Modulating Oxidative Stress in Puromycin-Induced Nephropathy. Pathophysiology. 2025; 32(2):19.
https://doi.org/10.3390/pathophysiology32020019
Chicago/Turabian Style
Iizuka, Yusuke, Masanori Sasaki, Kojiro Terada, Takuro Sakai, Yoshinobu Nagaoka, Shinobu Fukumura, Jeffery D. Kocsis, Takeshi Tsugawa, and Osamu Honmou.
2025. "Therapeutic Efficacy of Mesenchymal Stem Cells in Modulating Oxidative Stress in Puromycin-Induced Nephropathy" Pathophysiology 32, no. 2: 19.
https://doi.org/10.3390/pathophysiology32020019
APA Style
Iizuka, Y., Sasaki, M., Terada, K., Sakai, T., Nagaoka, Y., Fukumura, S., Kocsis, J. D., Tsugawa, T., & Honmou, O.
(2025). Therapeutic Efficacy of Mesenchymal Stem Cells in Modulating Oxidative Stress in Puromycin-Induced Nephropathy. Pathophysiology, 32(2), 19.
https://doi.org/10.3390/pathophysiology32020019
